SEPTUM ATTACHED VENTRICULAR SUPPORT
    1.
    发明申请
    SEPTUM ATTACHED VENTRICULAR SUPPORT 审中-公开
    SEPTUM附着的心脏支持

    公开(公告)号:US20070208211A1

    公开(公告)日:2007-09-06

    申请号:US11745260

    申请日:2007-05-07

    IPC分类号: A61B17/00

    CPC分类号: A61F2/2481

    摘要: A method and device are disclosed for treating congestive heart disease. The material of the device is secured to the heart proximate the septal wall. The material covering the ventricles may or may not have the same tension and or compliance. The device can be constructed as a unitary “jacket” that is slipped over the apex of the heart. Alternately, the device implanted as one, two or more separate components. In one embodiment, the material covers both the left and right ventricles. In another embodiment, the material covers only one ventricle. The device may include at least one adjustment mechanism configured to adjust the tension of the material. Preferably, the device includes a first adjustment mechanism configured to adjust a tension of the material covering the right ventricle and a second adjustment mechanism configured to adjust the tension of the material covering the left ventricle such that the tension of the material covering the left ventricle can be different than the tension of the material covering the right ventricle.

    摘要翻译: 公开了治疗充血性心脏病的方法和装置。 该装置的材料固定在靠近隔壁的心脏上。 覆盖心室的材料可能具有或不具有相同的张力和/或顺应性。 该装置可以被构造成整体的“夹克”,其被滑过心脏的顶点。 或者,该装置作为一个,两个或更多个分离的部件植入。 在一个实施例中,材料覆盖左心室和右心室。 在另一个实施例中,材料仅覆盖一个心室。 该装置可以包括被配置为调节材料张力的至少一个调节机构。 优选地,该装置包括被配置为调节覆盖右心室的材料的张力的第一调节机构和被配置为调节覆盖左心室的材料的张力的第二调节机构,使得覆盖左心室的材料的张力可以 与覆盖右心室的材料的张力不同。

    Regional cardiac tissue treatment
    2.
    发明申请
    Regional cardiac tissue treatment 有权
    区域心脏组织治疗

    公开(公告)号:US20070060907A1

    公开(公告)日:2007-03-15

    申请号:US11490476

    申请日:2006-07-20

    IPC分类号: A61M31/00

    摘要: A method for treating an occlusion in a coronary artery of a patient includes percutaneously advancing an occlusion treatment tool (such as an angioplasty balloon or stent delivery device) through the vasculature of the patient and into a coronary artery to a site of the occlusion. Following the treatment of the occlusion, a therapeutic agent is admitted into the first coronary artery. The therapeutic agent is selected to treat microvasculature obstructions at a target cardiac tissue site distal to the site of the occlusion.

    摘要翻译: 用于治疗患者冠状动脉闭塞的方法包括通过患者的脉管系统经皮推进闭塞治疗工具(例如血管成形术球囊或支架输送装置)并进入冠状动脉至闭塞部位。 治疗闭塞后,治疗剂进入第一冠状动脉。 治疗剂被选择用于治疗位于闭塞部位远端的靶心脏组织部位的微血管阻塞物。